British HIV Association guidelines for the management of HIV-2 2021

Affiliations

¹ Consultant in HIV Medicine, Homerton University Hospital NHS Trust, London, UK.
² UK Community Advisory Board representative.
³ Clinical Senior Lecturer in HIV, Barts and the London, Queen Mary University of London, London, UK.
⁴ Consultant in Sexual Health and HIV Medicine, Barts Health NHS Trust, London, UK.
⁵ Consultant Virologist, National Infection Service, Public Health England, UK.
⁶ Consultant Physician Sexual Health and HIV, Kings College Hospital, London, UK.
⁷ Specialist Registrar in Infectious Diseases and Microbiology, Manchester University NHS Foundation Trust, Manchester, UK.
⁸ Consultant in Infectious Diseases, North Manchester General Hospital, Manchester, UK.

Free article

Iain Reeves et al. HIV Med. 2021 Dec.

Free article

. 2021 Dec:22 Suppl 4:1-29.

doi: 10.1111/hiv.13204.

¹ Consultant in HIV Medicine, Homerton University Hospital NHS Trust, London, UK.
² UK Community Advisory Board representative.
³ Clinical Senior Lecturer in HIV, Barts and the London, Queen Mary University of London, London, UK.
⁴ Consultant in Sexual Health and HIV Medicine, Barts Health NHS Trust, London, UK.
⁵ Consultant Virologist, National Infection Service, Public Health England, UK.
⁶ Consultant Physician Sexual Health and HIV, Kings College Hospital, London, UK.
⁷ Specialist Registrar in Infectious Diseases and Microbiology, Manchester University NHS Foundation Trust, Manchester, UK.
⁸ Consultant in Infectious Diseases, North Manchester General Hospital, Manchester, UK.

No abstract available

Keywords: CD4; HIV-2; antiretroviral.

MeSH terms